MMP-9 directed shRNAs as relevant inhibitors of matrix metalloproteinase 9 activity and signaling

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0

Abstract

Introduction: The main function of matrix metalloproteinases is the degradation of extracellular matrix components, which is related to changes in the proliferation of cells, their differentiation, motility, and death. MMPs play an important role in physiological processes such as embryogenesis, angiogenesis and tissue remodeling. The increase of MMPs activity is also observed in pathological conditions including tumorigenesis where MMP-2 (gelatinase A) and MMP-9 (gelatinase B) show the ability to degrade the basement membrane of vessels and they are involved in metastasis. The aim of our study was to verify the changes of MMP-9 enzymatic activity and the mobility of cells after inhibition of MMP-9 gene expression.Material and Methods: The oligonucleotide shRNA insert had been designed to silence MMP-9 gene expression and was cloned into the pSUPER.neo expression vector. The construct was introduced into the HeLa (CCL-2) cervical cancer cells by lipotransfection. Simultaneously in control cells MMP-9 were inhibited by doxycycline. Changes in activity of MMP-9 were analyzed by gelatin zymography and wound-healing assay.Results/Conclusions: Gelatin zymography allowed us to confirm that activity of MMP-9 in cells transfected by shRNA-MMP-9 and treated by doxycycline were similar and significantly lower in comparison with control cells. Phenotypic tests of migration in vitro confirm statistically significant (P<0.05) changes in cell migration – control cells healed 3 to 5 times faster in comparison with transfected or doxycycline treated cells. Our studies show the significant role of MMP-9 in mobility and invasiveness of tumor cells, thus indicating a potential target point of interest for gene therapy.

Authors and Affiliations

Ewa Nowak, Anna Galilejczyk, Daniel Sypniewski, Ilona Bednarek

Keywords

Related Articles

Beta-blokery i statyny w astmie

Astma jest chorobą o złożonej patogenezie i różnorodnym obrazie klinicznym, u podłoża której leży toczący się w drogach oddechowych proces zapalny. W patogenezę tej choroby zaangażowanych jest wiele komórek i substancji...

Znaczenie diagnostyczne nowego markera KIM-1 w uszkodzeniach nerek

Rozwijające się lawinowo w ostatnich latach badania naukowe, wyłaniają nowe markery do oceny nieuchwytnego dotychczas okresu choroby przed ujawnieniem się jej skutków klinicznych.Dzięki badaniom eksperymentalnym przeprow...

Reakcja nadwrażliwości kontaktowej, jej mechanizm i regulacja

Reakcja nadwrażliwości kontaktowej (CS) na hapteny jest klasycznym przykładem odpowiedzi komórkowej. W reakcji tej można wyróżnić dwie kolejno po sobie występujące fazy: wczesną występującą już 2 godziny od kolejnego kon...

3-Bromopyruvate as a potential pharmaceutical in the light of experimental data

3-Bromopyruvate (3-BrPA) is an halogenated analogue of pyruvic acid known for over four decades as an alkylating agent reacting with thiol groups of many proteins. It enters animal cells like a lactate: via monocarboxyli...

Hen’s egg as a source of valuable biologically active substances

The aim of this article is to show current knowledge concerning valuable substances biologically active present in hen eggs and underline important nutritive role of hen eggs. Hen egg is a good source of nutrients such a...

Download PDF file
  • EP ID EP67000
  • DOI -
  • Views 129
  • Downloads 0

How To Cite

Ewa Nowak, Anna Galilejczyk, Daniel Sypniewski, Ilona Bednarek (2013). MMP-9 directed shRNAs as relevant inhibitors of matrix metalloproteinase 9 activity and signaling. Advances in Hygiene and Experimental Medicine, 67(0), 742-749. https://europub.co.uk/articles/-A-67000